 |
 |

Drug-Induced Neutropenias: Now and Then
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In a recent article by van der Klauw et al,1 it was observed that the highest risks for developing drug-induced agranulocytosis were found for thyroid inhibitors, sulfamethoxazole-trimethoprim, sulfasalazine, chlomipramine hydrochloride, and dipyrone combined with analgesics. In a less sophisticated survey of all cases of drug-induced neutropenia that were reported into the computerized patient diagnosis register in Stockholm, Sweden, more than 20 years ago, my colleague and I2 found strikingly similar results. Although the panorama of drugs that are available in the marketplace has changed so much over the years, those causing neutropenia are still very similar and still on the market. It is of interest to note that although agranulocytosis (and other blood dyscrasias) caused by sulfamethoxazole-trimethoprim is seldom fatal, it is extremely costly for society.3
Jan Palmblad, MD, PhD
Huddinge, Sweden
1. van der Klauw MM, Goudsmit R, Halie MR, et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 1999;159:369-374.
FREE FULL TEXT
2. Arneborn P, Palmblad J. Drug-induced neutropenia: survey for Stockholm 1973-1978. Acta Med Scand. 1982;212:289-292.
PUBMED
3. Keisu M, Wiholm BE, Palmblad J. Trimethoprim-sulfamethoxazoleassociated blood dyscrasias. J Intern Med. 1990;228:353-360.
WEB OF SCIENCE
| PUBMED
In reply
We would like to thank Dr Palmblad for his interest in our article.1 Indeed, In their . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Hyponatremia
Arieff et al.
NEJM 2000;343:886-888.
FULL TEXT
Drug-Induced Allergic Cytopenia: In Vitro Confirmation by the Lymphocyte Transformation Test
Sachs et al.
Arch Intern Med 2000;160:2218-2219.
FULL TEXT
|